retatrutide clinical trial results 2024 A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Pharmacology Eli Lilly touts strong results

Step 2: Drawing the Diluent Take your 3mL syringe and draw up your desired amount of Bacteriostatic Water

Wegovy's list price is approximately $1,350 per month for the 2.4 mg maintenance dose

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

Consider retatrutide if: You have already tried tirzepatide at max tolerated dose and plateaued

The FDA and CDC linked the outbreak to nearly 1.6 million dozen eggs recalled from Texas farms

The drug may hold promise for heart health and liver issues